Trust Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.12M Hold
19,589
– – 0.31% 24
2026
Q2
$4.93M Sell
19,589
-33
-0.2% -$7.1K 0.31% 27
2026
Q1
$4.27M Hold
19,622
– – 0.31% 23
2025
Q4
$4.48M Sell
19,622
-724
-4% -$165K 0.31% 22
2025
Q3
$4.71M Hold
20,346
– – 0.32% 24
2025
Q2
$3.78M Hold
20,346
– – 0.28% 25
2025
Q1
$4.26M Sell
20,346
-10
-0% -$1.94K 0.35% 24
2024
Q4
$3.62M Hold
20,356
– – 0.28% 26
2024
Q3
$4.02M Hold
20,356
– – 0.32% 24
2024
Q2
$3.49M Hold
20,356
– – 0.29% 25
2024
Q1
$3.71M Hold
20,356
– – 0.32% 25
2023
Q4
$3.15M Hold
20,356
– – 0.3% 26
2023
Q3
$3.03M Hold
20,356
– – 0.33% 24
2023
Q2
$2.74M Hold
20,356
– – 0.28% 25
2023
Q1
$3.24M Buy
20,356
+347
+2% +$53.1K 0.37% 22
2022
Q4
$3.23M Hold
20,009
– – 0.4% 23
2022
Q3
$2.68M Buy
20,009
+1,395
+7% +$200K 0.37% 24
2022
Q2
$2.85M Buy
18,614
+915
+5% +$140K 0.4% 23
2022
Q1
$2.87M Buy
17,699
+618
+4% +$89.8K 0.35% 24
2021
Q4
$2.31M Hold
17,081
– – 0.29% 32
2021
Q3
$1.84M Buy
17,081
+1,140
+7% +$130K 0.25% 41
2021
Q2
$1.8M Buy
15,941
+1,752
+12% +$197K 0.24% 37
2021
Q1
$1.54M Buy
14,189
+2,525
+22% +$270K 0.2% 42
2020
Q4
$1.25M Buy
11,664
+2,727
+31% +$262K 0.19% 40
2020
Q3
$783K Buy
8,937
+3,982
+80% +$375K 0.14% 42
2020
Q2
$486K Buy
+4,955
New +$436K 0.09% 42

Other funds holding ABBV

Trust Asset Management's ABBV Position: Q3 2026 in Review

Trust Asset Management held its AbbVie (ABBV) position steady in Q3 2026 at 19,589 shares worth $5.12M. The position accounts for 0.31% of the portfolio, ranked #24.

Trust Asset Management first reported a position in ABBV in Q2 2020 and has held it in 26 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Trust Asset Management held 19,589 shares of AbbVie worth $5.12M as of Q3 2026.
  • Trust Asset Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.31% of Trust Asset Management's portfolio in Q3 2026, its #24 holding.
  • Trust Asset Management first reported a position in AbbVie in Q2 2020 and has held it in 26 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Trust Asset Management's 13F filing for Q3 2026, filed 3 Nov 2026.